Veracyte, Inc (VCYT) PT Lowered to $37 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Kallum Titchmarsh lowered the price target on Veracyte, Inc (NASDAQ: VCYT) to $37.00 (from $48.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
